期刊文献+
共找到417篇文章
< 1 2 21 >
每页显示 20 50 100
Exploring the Mechanism of Yougui Pill against Aging Based on Network Pharmacology and Molecular Docking Study
1
作者 Haiyan Yang Qian Shi Chunchun Ji 《Chinese Medicine and Natural Products》 2025年第1期47-58,共12页
Objective This study aimed to explore the mechanism of obtaining yang from yin in Yougui pill against aging based on network pharmacology and molecular docking technology.Methods The active components and targets of Y... Objective This study aimed to explore the mechanism of obtaining yang from yin in Yougui pill against aging based on network pharmacology and molecular docking technology.Methods The active components and targets of Yougui Pill were obtained by searching the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP)database and the Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine(BATMEN-TCM)database,and kidney deficiency syndrome-related targets were obtained in the Symptom Mapping(SymMap)Database,a traditional Chinese medicine(TCM)syndrome correlation database.The protein–protein interaction(PPI)network was constructed by using the STRING11.5 database.Then,we used CytoScape3.9.0 software to construct the network of TCM–active components–potential targets,and the core TCM components and core targets of Yougui Pill for the treatment of kidney deficiency were obtained.The function analysis of Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)signaling pathway enrichment analysis were performed in the Database for Annotation,Visualization,and Integrated Discovery(DAVID).Finally,preliminary verification was performed with the help of molecular docking technology.Results A total of 147 active components of 9 drugs of Yougui Pill(Fuzi[Aconiti Lateralis Radix Praeparata],Shudihaung[Rehmanniae Radix Praeparata],Gouqi[Lycii Fructus],Shanyao[Rhizoma Dioscoreae],Shanzhuyu[Corni Fructus],Tusizi[Cuscutae Semen],Danggui[Angelicae Sinensis Radix],Duzhong[Eucommiae Cortex],Lujiaojiao[Cervi Cornus Colla])were obtained,corresponding to 233 targets.A total of 2,235targets related to kidney deficiency syndrome and 43 potential therapeutic targets were obtained after the intersection.The core TCM components mainly included quercetin,kaempferol,diosgenin,β-carotene,etc.The core targets involved Trp53(Tp53),Akt1,Pparg,Nr3c1,App,Casp8,Mapk1,Cav1,and Ctnnb1.A total of 27biological processes,10 cellular components,and 11 molecular functions were obtained by gene function enrichment analysis,mainly related to the regulation of gene expression,cell apoptosis and proliferation,and the response to estrogen.A total of 51 KEGG signaling pathways,mainly involving a variety of cancer pathways,apoptosis pathways,longevity regulation pathways,etc.Conclusion Yougui Pill can play a role in preventing and treating kidney deficiency syndrome through multiple targets and pathways. 展开更多
关键词 yougui Pill AGING kidney deficiency syndrome obtaining Yangfrom Yin network pharmacology molecular docking
原文传递
Zuogui(左归丸)and Yougui pills(右归丸)improve perimenopausal syndrome via regulation of apoptosis in mice 被引量:3
2
作者 WANG Tianqi LI Zining +5 位作者 CHEN Ting CHEN Rui JIN Ya Oduro Patrick kwabena ZHANG Han WANG Yi 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2023年第3期474-483,共10页
OBJECTIVE:To examine,dissect,and understand the molecular mechanisms and combinatorial effects of Zuogui(左归丸,ZGP)and Yougui pills(右归丸,YGP)in 4-vinyl cyclohexene diepoxide(4-VCD)-induced Perimenopausal syndrome(P... OBJECTIVE:To examine,dissect,and understand the molecular mechanisms and combinatorial effects of Zuogui(左归丸,ZGP)and Yougui pills(右归丸,YGP)in 4-vinyl cyclohexene diepoxide(4-VCD)-induced Perimenopausal syndrome(PMS).METHODS:Using the 4-VCD-induced PMS mouse model,uterine and ovary index were measured,and serum sex steroidal hormone levels were evaluated after treatment with ZGP,YGP,ZGP+YGP,estradiol valerate(EV),and Gengnian An(更年安,GNA).Histopathological examinations,ingredient-target network predictions,western blotting,and real-time quantitative polymerase chain reaction(RT-q PCR)analyses were performed to ascertain the possible pharmacological effects and molecular mechanisms of ZYP and YGP.RESULTS:Treatment with ZGP and YGP remarkably improves estrous cyclicity and prevents pathological damage to the uterus.Also,altered sex hormones,including AMH,E2,FSH,LH,P,and T,were restored to normal levels after ZGP and YGP administration.Ingredient-target network analysis showed that the 5 ingredients common to the ZGP and YGP formula modulate 53 targets shared with PMS.Pathwayenrichment analysis further predicted that ZGY and YGP likely regulate of apoptosis and other essential pathways during PMS.In-vivo studies showed that ZGP and YGP suppress PMS via modulating apoptosis through decreasing Caspase-3 and Bcl-2-associated X(Bax)levels and increasing B-cell lymphoma-2(Bcl-2)/Bax and Bcl-2 levels.Importantly,ZGP+YGP treatment modulation effects were somewhat or significantly better compared to ZGP or YGP alone treatment.CONCLUSION:ZGP and YGP represent novel anti-PMS agents whose effects involve restoring altered hormonal levels,protecting the uterus,and regulating apoptosis. 展开更多
关键词 PERIMENOPAUSE APOPTOSIS Zuogui pill yougui pill 4-vinyl cyclohexene diepoxide
原文传递
Systematic review of Yougui pills combined with levothyroxine sodium in the treatment of hypothyroidism
3
作者 Xiao-Pei Liu Ya-Nan Zhou Cong-E Tan 《World Journal of Clinical Cases》 SCIE 2022年第17期5690-5701,共12页
BACKGROUND Yougui pills have long been used to treat hypothyroidism,usually in combination with levothyroxine sodium in clinical treatment,while their clinical efficacy and safety are still controversial when compared... BACKGROUND Yougui pills have long been used to treat hypothyroidism,usually in combination with levothyroxine sodium in clinical treatment,while their clinical efficacy and safety are still controversial when compared to levothyroxine treatment alone.AIM To explore the clinical efficacy and safety of Yougui pills combined with levothyroxine sodium in the treatment of hypothyroidism.METHODS This meta-analysis was performed in accordance with the PRISMA guidelines.Randomized controlled trials on Yougui pills in the treatment of hypothyroidism published from 2008 to May 2021 were searched in a total of 8 databases(4 databases in Chinese and 4 databases in English).The quality of the included studies was evaluated according to the Cochrane risk assessment tool.Weighted mean difference(WMD)was used for continuous variables,and relative risk(RR)was used for binary variables.Data were extracted,and the meta-analysis was conducted with the statistical software of Stata15.0 and RevMan5.0.RESULTS A total of 140 articles were retrieved,and 9 of them were finally included,with a total sample size of 936 cases.The main meta-analysis results are as follows:(1)The group of Yougui pills combined with levothyroxine sodium had a significantly higher overall response rate than the group of levothyroxine sodium(RR=1.20,95%CI 1.12,1.28,P<0.00001);(2)Yougui pills combined with levothyroxine sodium achieved significantly better efficacy than levothyroxine sodium alone in alleviating adverse symptoms[standard mean difference(SMD)=-1.10,95%CI:-1.37,-0.84,P<0.00001];(3)The level of thyrotropin stimulating hormone in the group of Yougui pills combined with levothyroxine sodium was significantly lower than in the control group of levothyroxine sodium(WMD=-1.38,95%CI:-2.10,-0.67,P=0.00001);(4)The level of free triiodothyronine in the group of Yougui pills combined with levothyroxine sodium was higher than that in the control group of levothyroxine sodium(WMD=0.41,95%CI:0.03,0.79,P=0.03);(5)The level of free thyroxine in the group of Yougui pills combined with levothyroxine sodium was significantly higher than that in the control group of levothyroxine sodium(SMD=0.83,95%CI:0.44,1.22,P≤0.0001);and(6)The adverse reactions in the group of Yougui pills combined with levothyroxine sodium were significantly less than those in the control group of levothyroxine sodium(RR=0.33,95%CI:0.20,-0.53,P<0.00001).CONCLUSION In the treatment of hypothyroidism,the combination of Yougui pills with levothyroxine sodium may be better than levothyroxine sodium treatment alone. 展开更多
关键词 yougui pills Levothyroxine sodium HYPOTHYROIDISM Systematic review
暂未订购
Chinese herbal medicine Yougui Pill reduces exogenous glucocorticoid-induced apoptosis in anterior pituitary cells
4
作者 Yong-zhi Ji Long Geng +2 位作者 Hong-bo Zhou Hua-chen Wei Hong-duo Chen 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第12期1962-1968,共7页
Long-term glucocorticoid use may result in sustained suppression of one or more secreted components from the hypothalamo-pituitary-adrenal axis, and often results in apoptosis. Yougui Pill(YGP), a 10-component tradi... Long-term glucocorticoid use may result in sustained suppression of one or more secreted components from the hypothalamo-pituitary-adrenal axis, and often results in apoptosis. Yougui Pill(YGP), a 10-component traditional Chinese herbal medicine, has been shown to be clinically effective for glucocorticoid-induced suppression of the hypothalamo-pituitary-adrenal axis. However, the pharmacological and molecular mechanisms remain unclear. We hypothesized that YGP would exert an anti-apoptosis effect on dexamethasone-treated anterior pituitary cells. In vivo experiments showed that YGP significantly reduced the number of apoptotic cells, down-regulated m RNA expression of cytochrome c, caspase-3, and caspase-9, and up-regulated m RNA expression of Bcl-2. These findings suggest that YGP reduced glucocorticoid-induced apoptosis in rat anterior pituitary cells by regulating the mitochondria-mediated apoptosis pathway. 展开更多
关键词 nerve regeneration yougui Pill glucocorticoid apoptosis Bcl-2 cytochrome c caspase-3 caspase-9 mitochondrial membrane potential neural regeneration
暂未订购
Preliminary Study on the Differentiation of Bone Marrow Mesenchymal Stem Cells into Chondrocytes Induced by TGF-β1, Yougui Yin Drug-Containing Serum and Mechanical Stimulation
5
作者 Zengping Lin Kanghua Zheng +4 位作者 Darong Nie Huoquan Ye Hongjie Zhang Linfeng Tang Zhong Dong 《Journal of Biosciences and Medicines》 2024年第12期219-228,共10页
Objective: Bone marrow mesenchymal stem cells (BMSCs) have the potential to differentiate into chondrocytes, it is the ideal seed cells for treating cartilage injury. The purpose of this study was to investigate the i... Objective: Bone marrow mesenchymal stem cells (BMSCs) have the potential to differentiate into chondrocytes, it is the ideal seed cells for treating cartilage injury. The purpose of this study was to investigate the inducible factors that stimulate the differentiation of bone marrow mesenchymal stem cells into chondrocytes. Methods: Rat BMSCs were isolated and subcultured, and then inoculated on PLGA scaffolds after successfully identificating of BMSCs. They were divided into 5 groups. Blank serum group, TGF-β1 + Yougui Yin drug-containing serum induction group, TGF-β1 + mechanical stimulation induction group, Yougui Yin drug-containing serum + mechanical stimulation induction group, TGF-β1 + Yougui Yin drug-containing serum + mechanical stimulation induction group, 4 weeks later, the adhesion status of cells and scaffolds was observed by Scanning Electron Microscopy, and then chondrocyte induction was performed on different treatment groups. After induction, the expression of Aggrecan and Collagen II was detected by immunofluorescence, and the mRNA expression of Aggrecan and Collagen II was detected by qPCR. Results: BMSCs were identified as rat bone marrow mesenchymal stem cells by immunofluorescence CD34 and CD44 cells. Scanning Electron Microscopy observed that BMSCs grew well on PLGA. Compared with PLGA group, the scaffold space of BMSCS-PLGA composite was significantly reduced, and the growth of cell adhesion scaffold was significantly increased. Compared with the blank serum group, the expression of Aggrecan in TGF-β1 + Yougui Yin drug-containing serum group and Yougui Yin drug-containing serum + mechanical stimulation group was significantly increased. The expression of Collagen II in TGF-β1 + Yougui Yin medicated serum group, Yougui Yin medicated serum + mechanical stimulation group, TGF-β1 + mechanical stimulation group and TGF-β1 + Yougui Yin medicated serum + mechanical stimulation group were significantly increased;PCR results showed that compared with blank serum group, the expression of Aggrecan in other groups was significantly increased, except for Collagen II expression in Yougui Yin drug-containing serum + mechanical stimulation group. Conclusion: BMSCs can differentiate into chondrocytes on PLGA scaffold. Compared with blank serum group, BMSCs can be induced to differentiate into chondrocytes in all induction groups, among all induction groups, TGF-β1 + Yougui-yin drug-containing serum group and TGF-β1 + mechanical stimulation group were more significant, and the difference was statistically significant. 展开更多
关键词 BMSCs yougui Yin Drug-Containing Serum TGF-Β1 Mechanical Stimulation PLGA Chondrocyt
暂未订购
Network pharmacological study of Zuogui pill and Yougui pill for the treatment of postmenopausal osteoporosis
6
作者 Jie Ding Shan-Shan Mei +1 位作者 Zhe-Xin Ni Chao-Qin Yu 《Aging Communications》 2022年第3期4-13,共10页
Background:Postmenopausal osteoporosis(PMO)is the most common primary osteoporosis in older women.This condition imposes a huge economic and medical burden on society.Aside from western medicine,traditional Chinese me... Background:Postmenopausal osteoporosis(PMO)is the most common primary osteoporosis in older women.This condition imposes a huge economic and medical burden on society.Aside from western medicine,traditional Chinese medicine is also widely used for the treatment of PMO,especially in Asian countries.Zuogui pill(ZGP)and Yougui pill(YGP)are classical formulas for the treatment of PMO with potent clinical effects.This study aimed to explore the potential active compounds,potential targets,and potential mechanisms of ZGP and YGP for the treatment of PMO.Methods:Compounds from ZGP and YGP were collected from three online databases,and these compounds were screened by oral bioavailability and drug-likeness.Their corresponding targets were determined from the Medicine Systems Pharmacology Database and Analysis platform.The corresponding targets for PMO were obtained from two disease databases.The target protein-protein interaction was identified through the STRING platforms and the core targets were ascertained by analyzing the protein-protein interaction network by using Cytoscape software.PMO-related genes were identified via Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses to identify specific biological processes,cellular components,molecular functions and key signalling pathways of ZGP and YGP for PMO treatment.Results:A total of 68 compounds were screened from ZGP with 168 putative potential target genes,whereas 99 compounds were screened from YGP with 214 potential target genes associated with PMO.Most of the core components included quercetin and kaempferol,and most of the core targets were TP53,AKT1,MAPK1,JUN,TNF,HSP90AA1,APP,IL6,VEGFA,RELA,MAPK8,NR3C1,EGFR,CXCL8,ESR1,FOS and MAPK14.Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analyses revealed that ZGP and YGP treat PMO primarily via regulation of bone formation and resorption,anti-inflammatory immunity and hormonal regulation.Conclusion:Our data provided insights into the mechanisms,by which ZGP and YGP treat PMO.This study points out a direction for further research into ZGP and YGP monomers and pathways and offers a new clinical treatment option for non-traditional Chinese medicine clinicians in the treatment of PMO. 展开更多
关键词 Zuogui pill yougui pill postmenopausal osteoporosis network pharmacological
暂未订购
自然衰老大鼠骨髓蛋白质组学的变化及右归饮的改善作用及其机制
7
作者 冉海凤 魏晓茹 +4 位作者 万柯希 陈怡 俸珊 张继芬 徐晓玉 《中国中药杂志》 北大核心 2026年第4期1043-1052,共10页
观察自然衰老大鼠骨髓蛋白质组学变化和右归饮的改善作用及其机制。将自然衰老大鼠分组灌胃给药右归饮60 d,观察大鼠外观、脏器组织形态、生化及骨髓蛋白变化;给予右归饮干预D-半乳糖(D-gal)诱导衰老的骨髓间充质干细胞(BM-SCs),检测其... 观察自然衰老大鼠骨髓蛋白质组学变化和右归饮的改善作用及其机制。将自然衰老大鼠分组灌胃给药右归饮60 d,观察大鼠外观、脏器组织形态、生化及骨髓蛋白变化;给予右归饮干预D-半乳糖(D-gal)诱导衰老的骨髓间充质干细胞(BM-SCs),检测其增殖能力、成骨分化能力、氧化指标及骨髓蛋白变化。结果显示,经蛋白质组学筛选蛋白及蛋白免疫印迹法(WB)验证,自然衰老大鼠骨髓中NADPH氧化酶2(NOX2)、转铁蛋白受体蛋白1(TFR1)蛋白显著升高,血红素加氧酶-1(HO-1)、铁蛋白重链1(FTH1)蛋白显著降低。右归饮组大鼠外观、脏器指数、肾和脾脏组织形态、血常规、肝肾功能指标均显著改善,血清超氧化物歧化酶(SOD)、总抗氧化能力(T-AOC)、谷胱甘肽(GSH)显著升高,活性氧(ROS)、丙二醛(MDA)显著降低,骨髓中ROS显著降低;右归饮组BMSCs细胞活性、成骨分化能力均显著升高,衰老细胞β-半乳糖苷酶染色减少,ROS显著下降。右归饮组大鼠骨髓和BMSCs中NOX2、TFR1蛋白表达显著降低,核转录因子红系2相关因子2(NRF2)、HO-1、FTH1蛋白表达显著升高。综上,自然衰老大鼠的骨髓老化,与氧化相关蛋白NOX2、TFR1显著升高,HO-1、FTH1显著降低有关;右归饮对自然衰老大鼠体质有显著改善作用;对其骨髓老化的改善作用机制,与其显著降低NOX2、TFR1,显著升高NRF2、HO-1、FTH1,降低骨髓脂质过氧化及其细胞铁死亡有关。 展开更多
关键词 自然衰老大鼠 骨髓蛋白质组学 右归饮 脂质过氧化 氧化应激
原文传递
右归丸减缓膝骨关节炎模型大鼠软骨细胞焦亡的作用机制
8
作者 范元赫 杨永菊 +5 位作者 何璠玙 乔隆 张宇 张帅 李志文 关雪峰 《中国组织工程研究》 北大核心 2026年第24期6214-6219,共6页
背景:右归丸出自《景岳全书》,有研究证实右归丸对膝骨关节炎患者疗效显著,但作用机制尚不明确。目的:探讨右归丸改善大鼠膝骨关节炎的潜在分子作用机制。方法:48只SPF级SD大鼠采用随机数字表法分为4组,分别为空白组、模型组、右归丸组... 背景:右归丸出自《景岳全书》,有研究证实右归丸对膝骨关节炎患者疗效显著,但作用机制尚不明确。目的:探讨右归丸改善大鼠膝骨关节炎的潜在分子作用机制。方法:48只SPF级SD大鼠采用随机数字表法分为4组,分别为空白组、模型组、右归丸组、塞来昔布组,后3组采用改良Hulth法对大鼠膝关节进行手术造模,伤口愈合后驱赶8周。造模结束后,塞来昔布组大鼠灌胃塞来昔布混悬液,右归丸组大鼠灌胃右归丸水煎液,假手术组与模型组灌胃等体积生理盐水,1次/d,连续灌胃4周。采用苏木精-伊红染色、甲苯胺蓝染色、番红-固绿染色观察大鼠软骨组织病理变化,透射电镜观察大鼠软骨细胞超微结构,ELISA法检测大鼠血清中白细胞介素18、白细胞介素1β、肿瘤坏死因子α水平,Western blot法检测大鼠软骨组织PI3K、AKT、NF-κB、p-PI3K、p-AKT、p-P65、NLRP3、GSDMD、GSDMD-N、Caspase1、Cleaved-Caspase1、白细胞介素18、白细胞介素1β蛋白表达。结果与结论:①与空白组比较,模型组大鼠软骨边缘严重破坏,软骨组织缺损,软骨层细胞变薄、排列紊乱,软骨下骨增生,潮线紊乱,软骨细胞结构损伤严重、焦亡小体形成,血清肿瘤坏死因子α、白细胞介素18、白细胞介素1β水平显著升高(P<0.05),软骨组织p-PI3K、p-AKT、p-P65、NLRP3、GSDMD-N、Cleaved-Caspase1、白细胞介素18、白细胞介素1β蛋白表达均显著升高(P<0.01);②与模型组比较,右归丸组和塞来昔布组大鼠软骨结构趋于正常,软骨着色较深,软骨增厚,软骨细胞胞膜较完整,血清中肿瘤坏死因子α、白细胞介素18、白细胞介素1β水平显著减低(P<0.05),软骨组织p-PI3K、p-AKT、p-P65、NLRP3、GSDMD-N、Cleaved-Caspase1、白细胞介素18、白细胞介素1β蛋白表达显著降低(P<0.01);③与塞来昔布组比较,右归丸组软骨细胞排列较规整,关节软骨表面较光滑,软骨层增厚明显,潮线相对完整,软骨细胞胞膜相对完整,血清中肿瘤坏死因子α、白细胞介素18、白细胞介素1β水平显著减低(P<0.05),软骨组织p-PI3K、p-AKT、p-P65、NLRP3、GSDMD-N、Cleaved-Caspase1、白细胞介素18、白细胞介素1β蛋白表达显著降低(P<0.01)。结果表明,右归丸可改善膝骨关节炎大鼠软骨细胞炎症反应,作用机制可能与抑制PI3K/AKT/NF-κB通路的激活,从而调控NLRP3/Caspase1/GSDMD通路介导的细胞焦亡相关。 展开更多
关键词 右归丸 膝骨关节炎 中药 软骨 炎症 焦亡 信号通路
暂未订购
Effects of Zuogui Pill(左归丸) and Yougui Pill(右归丸) on the Expression of Brain-Derived Neurotrophic Factor and Cyclic Adenosine Monophosphate/Protein Kinase A Signaling Transduction Pathways of Axonal Regeneration in Model Rats with Experimental Autoimm 被引量:10
9
作者 王义周 寇爽 +5 位作者 谷凌云 郑琦 李明 齐放 赵晖 王蕾 《Chinese Journal of Integrative Medicine》 SCIE CAS 2014年第1期24-30,共7页
Objective:To study the effects of Zuogui Pill(左归丸,ZGP)and Yougui Pill(右归丸,YGP)on the expressions of brain-derived neurotrophic factor(BDNF)and cyclic adenosine monophosphate(cAMP)/protein kinase A(PKA... Objective:To study the effects of Zuogui Pill(左归丸,ZGP)and Yougui Pill(右归丸,YGP)on the expressions of brain-derived neurotrophic factor(BDNF)and cyclic adenosine monophosphate(cAMP)/protein kinase A(PKA)signaling of axonal regeneration in the Lewis rats with experimental autoimmune encephalomyelitis(EAE),in order to explore the possible mechanism of ZGP and YGP on promoting axonal regeneration.Methods:The rats were randomly divided into normal control(NC),model(MO),prednisone acetate(PA),ZGP and YGP groups.The EAE model of rat was established by injecting antigen containing myelin basic protein(MBP)68-86.The brain and spinal cord were harvested on the 14th and 28th day postimmunization(PI),the protein and mRNA expression of BDNF and PKA in the brain and spinal cord of rats were detected by Western blot analysis and real-time quantitative polymerase chain reaction(PCR),and the cAMP levels were detected by using enzyme-immunoassay method.Results:(1)On the 28th day PI,the mRNA expression of BDNF in brain white matter and spinal cord of rats in ZGP and YGP groups were up-regulated,especially in YGP group(P〈0.05 or P〈0.01).(2)On the 14th day PI,the cAMP levels in brain white matters significantly increased in PA and YGP groups compared with MO group(P〈0.05 or P〈0.01),and the cAMP level in YGP group was higher than that in ZGP group(P〈0.05).The cAMP level in spinal cord also significantly increased in YGP group compared with MO,PA and ZGP groups,respectively(P〈0.01).(3)On the 14th day PI,the PKA expression in spinal cord of rats in ZGP group was significantly decreased compared with MO and YGP groups,respectively(P〈0.05).(4)On the 28th day PI,there was a positive correlation between cAMP and PKA expression in the brain white matter of YGP rats.Conclusions:The results suggest that ZGP and YGP may promote axonal regeneration by modulating cAMP/PKA signal transduction pathway,but the targets of molecular mechanism of ZGP may be different from those of YGP. 展开更多
关键词 experimental autoimmune encephalomyelitis Zuogui Pill yougui Pill brain-derived neurotrophic factor cyclic adenosine monophosphate protein kinase A axonal injury and regeneration Chinese medicine
原文传递
Research on the Mechanism of Zuogui Pill(左归丸)and Yougui Pill(右归丸)in Promoting Axonal Regeneration in Model Rats of Autoimmune Encephalomyelitis 被引量:8
10
作者 王蕾 赵晖 +4 位作者 樊永平 龚海洋 李明 齐放 刘妍 《Chinese Journal of Integrative Medicine》 SCIE CAS 2010年第2期167-172,共6页
Objective:To study the molecular mechanism of Zuogui Pill(左归丸,ZGP) and Yougui Pill(右归丸,YGP) on axonal regeneration in rats with experimental autoimmune encephalomyelitis(EAE).Methods: EAE rat model was e... Objective:To study the molecular mechanism of Zuogui Pill(左归丸,ZGP) and Yougui Pill(右归丸,YGP) on axonal regeneration in rats with experimental autoimmune encephalomyelitis(EAE).Methods: EAE rat model was established by bilateral rear pedes subcutaneous injection of antigen made by mixing myelin basic protein(MBP) and complete Freud's adjuvant(CFA) in the volume ratio of 1:1.The pathological changes of axonal injury and regeneration in the brain and the spinal cord were observed on the 14th(the acute stage) and the 28th day(the remission stage) after modeling,with hematoxylin-eosin(HE) staining,silver stain, and immunohistochemical staining.The rats treated with prednisone acetate were taken as controls.Results: Observation under the light microscope with HE staining showed a sleeve-like change in rats' cerebrospinal parenchyma with inflammatory cell infiltration around the small vessels and neuronic denaturation,while silver staining showed excessive tumefaction and abscission of axon,and immunohistochemical analysis showed decreasing of nerve growth factor(NGF) expression at the acute stage of EAE,which was even more remarkable at the remission stage,showing significant difference as compared with the normal control(P〈0.05). And the expressions of Nogo A,an axon growth inhibitor,and its receptor(Nogo-66 receptor,Ng R) were significantly higher than those in the normal control at the acute stage(P〈0.01).However,after the intervention of ZGP and YGP,the pathological changes and axon damage in rats' brain and spinal cord were much more alleviated,and the NGF expression was significantly higher than that in the model group at the acute stage (P〈0.05).The expression of NGF was even stronger during the remission stage,and a better effect was shown by YGP.As for Nogo A and Ng R expressions,they were significantly lower than those in the model group at the acute stage(P〈0.05),but a better effect was shown by ZGP.Conclusions:ZGP and YGP can prevent axonal injury and promote the axonal regeneration in rats of EAE,and the possible mechanism is to increase the expression of NGF and reduce the expression of Nogo A and its receptor.However,some differences are observed between the two Chinese preparations in their acting times and points,which provides a certain basis for revealing the modern connotation of the Chinese medicine theory on tonifying Shen(肾)-yin and Shen-yang. 展开更多
关键词 Zuogui Pill yougui Pill experimental autoimmune encephalomyelitis axonal regeneration
原文传递
月经后应用右归丸加减治疗肾阳虚型月经性偏头痛的临床研究
11
作者 简雪珊 张芷如 +3 位作者 方浩涛 金远林 孔杰 黄汝成 《广州中医药大学学报》 2026年第1期43-48,共6页
【目的】探讨月经后应用右归丸加减治疗肾阳虚型月经性偏头痛的临床疗效及作用机制。【方法】回顾性筛选2024年2月至2025年2月深圳市宝安区中医院脑病科门诊病历,纳入100例肾阳虚型月经性偏头痛患者,根据实际治疗方案分为暴露组和对照组... 【目的】探讨月经后应用右归丸加减治疗肾阳虚型月经性偏头痛的临床疗效及作用机制。【方法】回顾性筛选2024年2月至2025年2月深圳市宝安区中医院脑病科门诊病历,纳入100例肾阳虚型月经性偏头痛患者,根据实际治疗方案分为暴露组和对照组各50例。暴露组给予右归丸加减联合盐酸氟桂利嗪治疗,对照组单纯给予盐酸氟桂利嗪治疗,2组均以1个月经周期为1个疗程,连续治疗3个疗程。观察2组患者治疗前及治疗3个月经周期后的偏头痛积分、头痛影响测评量表6(HIT-6)评分及血清雌二醇(E2)、5-羟色胺(5-HT)水平的变化情况,并评价2组患者的临床疗效及用药安全性。【结果】(1)疗效方面,治疗3个月经周期后,暴露组的总有效率为90.0%(45/50),对照组为76.0%(38/50),组间比较(χ^(2)检验),暴露组的临床疗效明显优于对照组(P<0.05)。(2)偏头痛积分方面,治疗3个月经周期后,2组患者的偏头痛积分均较治疗前明显降低(P<0.05),且暴露组的降低幅度明显优于对照组(P<0.05)。(3)对生活的影响方面,治疗3个月经周期后,2组患者的HIT-6评分均较治疗前明显降低(P<0.05),且暴露组的降低幅度明显优于对照组(P<0.05)。(4)血清学方面,治疗3个月经周期后,2组患者的血清E2、5-HT水平均较治疗前明显升高(P<0.05),且暴露组的升高幅度均明显优于对照组(P<0.05)。(5)安全性方面,治疗期间,2组患者均未发生严重不良反应,不良反应多为嗜睡、乏力、心情低落等,其中对照组的不良反应发生率为4.0%(2/50),暴露组为2.0%(1/50),组间比较,差异无统计学意义(P>0.05),且不良反应均较轻,无需特殊处理。【结论】月经后运用右归丸加减治疗肾阳虚型月经性偏头痛,可显著提高临床疗效,降低偏头痛发作程度、频率及持续时间,改善偏头痛症状,且无严重不良反应,有利于促进患者康复,安全性良好。 展开更多
关键词 右归丸加减 月经性偏头痛 肾阳虚型 疗效观察 经后治疗
原文传递
右归丸及其拆方调控HIF-1α/Sox9信号通路促进脱髓鞘模型小鼠髓鞘再生的作用机制研究
12
作者 李海馨 李辰 王蕾 《中国中医药信息杂志》 2026年第2期67-74,共8页
目的观察右归丸及其拆方对双环己酮草酰二腙(CPZ)诱导的脱髓鞘模型小鼠HIF-1α/Sox9信号通路的影响,探讨其促进髓鞘再生的作用机制。方法采用0.2%CPZ饲料喂养6周诱导小鼠脱髓鞘模型,采用随机数字表法将小鼠分为正常组、模型组、特立氟胺... 目的观察右归丸及其拆方对双环己酮草酰二腙(CPZ)诱导的脱髓鞘模型小鼠HIF-1α/Sox9信号通路的影响,探讨其促进髓鞘再生的作用机制。方法采用0.2%CPZ饲料喂养6周诱导小鼠脱髓鞘模型,采用随机数字表法将小鼠分为正常组、模型组、特立氟胺组(15 mg/kg)、右归丸组(2.4 g/kg)、补阳化气组(1.1 g/kg)和滋阴填精组(1.3 g/kg),每组12只,各给药组分别予相应药物灌胃,正常组和模型组予等体积蒸馏水,每日1次,连续2周。采用转棒和步态分析仪检测小鼠运动功能和协调能力,快蓝染色观察胼胝体形态,透射电镜观察髓鞘和轴突超微结构,免疫荧光法检测胼胝体髓鞘碱性蛋白(MBP)、少突胶质细胞转录因子2(Olig2)、CC1表达,Western blot检测脑组织缺氧诱导因子(HIF)-1α、性别决定区Y框蛋白9(Sox9)、髓鞘少突胶质细胞糖蛋白(MOG)蛋白表达。结果与正常组比较,模型组小鼠转棒维持时间显著缩短(P<0.001),后肢摆动步幅百分比显著升高(P<0.01,P<0.001),触地步幅百分比显著降低(P<0.001);脱髓鞘百分比和G-ratio显著升高(P<0.001),胼胝体MBP表达和CC1+Olig2+细胞占比显著降低(P<0.001),脑组织HIF-1α、Sox9蛋白表达显著升高(P<0.05),MOG蛋白表达显著降低(P<0.01)。与模型组比较,各给药组小鼠转棒维持时间显著延长(P<0.05,P<0.01),特立氟胺组和右归丸组小鼠后肢摆动步幅百分比显著降低(P<0.01,P<0.001),触地步幅百分比显著升高(P<0.01,P<0.001),补阳化气组和滋阴填精组小鼠右后肢摆动步幅百分比降低,触地步幅百分比升高(P<0.05);各给药组小鼠脱髓鞘百分比显著降低(P<0.05,P<0.01),G-ratio显著降低(P<0.001),特立氟胺组和右归丸组小鼠胼胝体MBP表达显著升高(P<0.01),CC1+Olig2+细胞占比显著升高(P<0.01),滋阴填精组MBP表达升高(P<0.05),补阳化气组CC1+Olig2+细胞占比显著升高(P<0.05),特立氟胺组和右归丸组小鼠脑组织HIF-1α、Sox9蛋白表达显著降低(P<0.05),MOG蛋白表达显著升高(P<0.05),补阳化气组Sox9蛋白表达显著降低(P<0.05),MOG蛋白表达显著升高(P<0.05)。结论右归丸及其补阳化气、滋阴填精拆方可不同程度减轻CPZ诱导的小鼠髓鞘损伤,促进髓鞘再生,以右归丸作用效果更明显,其作用机制可能与抑制HIF-1α/Sox9信号通路有关。 展开更多
关键词 右归丸 双环己酮草酰二腙 多发性硬化 髓鞘再生 HIF-1α/Sox9信号通路 小鼠
暂未订购
右归丸加减联合玉屏风散治疗肺肾气虚证慢性阻塞性肺疾病临床研究
13
作者 李燕 张晓雷 李艳斐 《陕西中医》 2026年第4期477-482,共6页
目的:探讨右归丸加减联合玉屏风散治疗肺肾气虚证慢性阻塞性肺疾病(COPD)的临床疗效。方法:选取82例肺肾气虚证COPD患者作为研究对象,采用随机数字表法分为对照组(n=41,西药治疗)和观察组(n=41,西药+右归丸加减联合玉屏风散治疗),两组... 目的:探讨右归丸加减联合玉屏风散治疗肺肾气虚证慢性阻塞性肺疾病(COPD)的临床疗效。方法:选取82例肺肾气虚证COPD患者作为研究对象,采用随机数字表法分为对照组(n=41,西药治疗)和观察组(n=41,西药+右归丸加减联合玉屏风散治疗),两组均治疗2个月。比较两组患者临床疗效、中医证候积分、治疗后6个月内急性加重次数、肺功能、炎症因子、气道重塑指标、免疫状态及用药不良反应发生情况。结果:观察组临床疗效显著优于对照组(P<0.05)。观察组主症积分、次症积分、总积分及轻度、中度、重度急性加重次数、肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-6、IL-17、基质金属蛋白酶-9(MMP-9)、碱性成纤维细胞生长因子(b-FGF)低于对照组(均P<0.05)。观察组第一秒用力呼气容积(FEV1)、用力肺活量(FVC)、FEV1/FVC、CD4^(+)/CD8^(+)、CD4^(+)、CD3^(+)水平显著高于对照组(均P<0.05)。结论:右归丸加减联合玉屏风散对肺肾气虚证COPD患者具有良好的治疗价值,可显著降低炎症因子及气道重塑指标水平,改善免疫功能及肺功能,减少急性加重次数,缓解临床症状。 展开更多
关键词 慢性阻塞性肺疾病 肺肾气虚证 右归丸 玉屏风散 肺功能 气道重塑
暂未订购
右归丸减轻雷公藤多苷片致Ⅱ型胶原诱导性关节炎模型大鼠生殖毒性作用及转录组学研究
14
作者 程生辉 叶田香 +5 位作者 刘宝月 晋志楠 时昆 霍亚静 韩毅丽 李会芳 《药物评价研究》 北大核心 2026年第1期98-107,共10页
目的 探讨右归丸对雷公藤多苷(TG)片所致Ⅱ型胶原诱导性关节炎(CIA)模型大鼠生殖毒性减毒作用及其机制。方法 采用牛Ⅱ型胶原乙酸溶液和弗氏完全佐剂诱导建立CIA大鼠模型,随机分为对照组、模型组、TG(72 mg·kg^(-1))组及右归丸(3 g... 目的 探讨右归丸对雷公藤多苷(TG)片所致Ⅱ型胶原诱导性关节炎(CIA)模型大鼠生殖毒性减毒作用及其机制。方法 采用牛Ⅱ型胶原乙酸溶液和弗氏完全佐剂诱导建立CIA大鼠模型,随机分为对照组、模型组、TG(72 mg·kg^(-1))组及右归丸(3 g·kg^(-1))+TG(72 mg·kg^(-1))组,连续给药4周。实验期间对关节炎指数进行评分,实验结束时检测血清中雌二醇(E_(2))、卵泡刺激素(FSH)和睾酮(T)含量,检测卵巢和睾丸脏器指数和组织病理学变化,通过转录组学进行RNA测序与差异基因筛选,并进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析;采用Western blotting法进行关键靶点验证。结果 与对照组比较,模型组大鼠关节炎指数显著升高(P<0.01);与模型组比较,TG组和右归丸+TG组显著降低(P<0.05、0.01)。与模型组比较,TG组的E_(2)和T含量显著降低(P<0.05);与TG组比较,右归丸+TG组的E_(2)和T含量显著回升(P<0.01)。与模型组比较,TG组卵巢和睾丸组织损伤明显,表现为卵泡数量减少、颗粒层变薄、精子数量减少等;与TG组比较,右归丸+TG组的组织病理损伤显著缓解。卵巢样本GO富集分析集中在“女性生殖发育”相关过程,如ovulation cycle process(排卵周期过程)、ovulation cycle(排卵周期)、female gonad development(女性性腺发育)、mammalian oogenesis stage(哺乳动物卵子发生阶段);KEGG富集分析集中在过氧化物酶体增殖物激活受体(PPAR)、脂肪酸代谢和转化生长因子-β(TGF-β)信号通路。睾丸样本GO富集分析集中在“脂肪细胞发育与免疫应答”过程,如white fat cell differentiation(白色脂肪细胞分化)、fat cell differentiation(脂肪细胞分化);KEGG富集分析集中在过氧化物酶体增殖物激活受体-γ(PPAR)、脂肪细胞脂解的调控通路。与模型组比较,TG组大鼠骨形态发生蛋白2(BMP2)、抗缪勒氏管激素(AMH)、抑制素A(INHBA)、抑制素B(INHBB)和脂肪酸结合蛋白4(FABP4)蛋白表达水平明显降低(P<0.05、0.01);与TG组比较,右归丸+TG组上述蛋白表达水平显著升高(P<0.05、0.01)。结论 右归丸能够显著减轻雷公藤多苷对CIA模型大鼠的生殖毒性,与其能调节TGF-β和PPAR信号通路密切相关。 展开更多
关键词 雷公藤多苷 右归丸 生殖毒性 转录组学 Ⅱ型胶原诱导性关节炎 过氧化物酶体增殖物激活受体 转化生长因子β
原文传递
基于网络药理学、分子对接及实验验证探究右归丸治疗骨关节炎作用机制
15
作者 于智同 关雪峰 +1 位作者 魏巍 谢雨馨 《中国中医药信息杂志》 2026年第4期33-40,共8页
目的基于网络药理学和动物实验验证探讨右归丸通过益肾补骨治疗骨关节炎的作用机制。方法通过TCMSP数据库获取右归丸方中药物活性成分及其靶点;利用GeneCards数据库获取疾病靶点;药物与疾病靶点取交集后构建蛋白相互作用网络和药物-成分... 目的基于网络药理学和动物实验验证探讨右归丸通过益肾补骨治疗骨关节炎的作用机制。方法通过TCMSP数据库获取右归丸方中药物活性成分及其靶点;利用GeneCards数据库获取疾病靶点;药物与疾病靶点取交集后构建蛋白相互作用网络和药物-成分-靶点网络,获取核心靶点;对交集靶点进行GO和KEGG通路富集分析,并进行分子对接以验证关键成分与核心靶点结合的稳定性。采用碘乙酸钠溶液双侧膝关节注射制备大鼠骨关节炎模型,将大鼠随机分为对照组、模型组、阳性药组及右归丸组,并予相应干预14 d,HE染色观察大鼠双膝软骨组织形态,qPCR检测软骨组织核因子(NF)-κB p65、NF-κB p50、基质金属蛋白酶(MMP)-13、血小板反应蛋白解整合素金属肽酶(ADAMTS)-5、IL-6 mRNA表达,Western blot检测软骨组织IKKβ、NF-κB p65、NF-κB p50、p-p38、MMP-13、环氧合酶(COX)-2蛋白表达,免疫组化染色检测软骨组织p-p38、MMP-13、COX-2阳性表达。结果网络药理学分析得到右归丸活性成分127个、对应靶点190个,骨关节炎相关靶点1266个,药物与疾病交集靶点46个,核心靶点为INS、IL10、IFNG、PTGS2、IL1A等。KEGG通路富集分析得到20条主要信号通路,包括肿瘤细胞信号通路、NF-κB信号通路、PI3K-AKT信号通路、细胞因子相互作用信号通路、神经变形通路等。动物实验显示,与对照组比较,模型组大鼠膝关节组织可见典型软骨损伤,骨表层结构缺失,软骨细胞排列紊乱,大量软骨细胞空泡变性,部分细胞核固缩碎裂,并可见细胞簇聚现象;软骨组织NF-κB p65、NF-κB p50、MMP-13、ADAMTS-5、IL-6 mRNA表达升高,NF-κB p65、NF-κB p50、p-p38、MMP-13、IKKβ、COX-2蛋白表达升高(P<0.05);与模型组比较,右归丸组大鼠膝关节软骨细胞炎性损伤明显改善,软骨组织MMP-13、ADAMTS-5、IL-6 mRNA表达及NF-κB p65、NF-κB p50、p-p38、MMP-13、IKKβ、COX-2蛋白表达显著降低(P<0.05)。结论右归丸可通过益肾补骨抑制NF-κB信号通路,进而降低ADAMTS-5、MMP-13、COX-2表达,减轻膝关节软骨的炎症和破坏,进而治疗骨关节炎。 展开更多
关键词 右归丸 骨关节炎 作用机制 信号通路 网络药理学
暂未订购
加味右归丸联用骨康胶囊治疗糖尿病骨质疏松的临床研究 被引量:1
16
作者 滕加文 陈文明 李宝锋 《辽宁中医杂志》 北大核心 2025年第12期89-92,共4页
目的探讨加味右归丸联用骨康胶囊对糖尿病性骨质疏松症患者骨转换指标及骨代谢的影响。方法收集2019年7月—2023年7月山东中医药大学附属医院骨伤科收治的糖尿病性骨质疏松症患者96例,根据随机数字分配表随机分为试验组和对照组,各48例... 目的探讨加味右归丸联用骨康胶囊对糖尿病性骨质疏松症患者骨转换指标及骨代谢的影响。方法收集2019年7月—2023年7月山东中医药大学附属医院骨伤科收治的糖尿病性骨质疏松症患者96例,根据随机数字分配表随机分为试验组和对照组,各48例,对照组予以骨康胶囊,试验组在对照组基础上予以加味右归丸。两组均治疗3个月。对比两组中医临床症状、血糖相关指标、骨密度、骨代谢、骨转换指标、临床疗效。根据SPSS 24.0进行统计学分析。结果治疗后两组腰背疼痛、腰膝酸软、抽筋乏力、下肢疼痛和下肢痿弱等症状评分均低于治疗前(P<0.05);试验组各项症状评分低于对照组(P<0.05);两组治疗前后血磷相、血钙比差异无统计学意义(P>0.05)。治疗后两组糖化血红蛋白(glycated hemoglobin,HbA1c)和空腹血糖(fasting blood glucose,FPG)水平、餐后2 h血糖(2-hour postprandial blood glucose,2 h PBG)水平低于治疗前(P<0.05);试验组FPG、2 h PBG和HbA1c水平低于对照组(P<0.05)。治疗后两组L1~L4、股骨大转子、股骨颈、总髋部骨密度高于治疗前(P<0.05);试验组各部位骨密度水平高于对照组(P<0.05)。治疗后与对照组比较,试验组总有效率较高(P<0.05)。治疗后两组血清骨钙素(osteocalcin,BGP)、碱性磷酸酶(alkaline phosphatase,ALP)均高于治疗前,抗酒石酸酸性磷酸酶-5b(tartrate-resistant acid phosphatase 5b,TRAP-5b)低于治疗前(P<0.05);试验组BGP、ALP均高于对照组,TRAP-5b低于对照组(P<0.05);两组治疗前后血磷相、血钙比差异无统计学意义(P>0.05)。结论加味右归丸联用骨康胶囊能够显著改善糖尿病性骨质疏松症患者的疗效,其治疗机制可能与调节骨转换指标、骨代谢水平具有密切相关性。 展开更多
关键词 加味右归丸 骨康胶囊 糖尿病性骨质疏松症 骨转换指标 骨代谢
原文传递
右归丸、涤痰汤化裁治疗多囊卵巢综合征对内分泌激素代谢和胰岛素抵抗的影响 被引量:1
17
作者 徐新亚 沈芳芳 相如兰 《中华中医药学刊》 北大核心 2025年第9期159-163,共5页
目的分析右归丸、涤痰汤化裁治疗多囊卵巢综合征对内分泌激素代谢和胰岛素抵抗的影响。方法选取2020年3月—2024年3月医院收治的多囊卵巢综合征患者102例为研究对象,51例对照组采用单纯西药治疗,51例观察组在上述基础上予以右归丸、涤... 目的分析右归丸、涤痰汤化裁治疗多囊卵巢综合征对内分泌激素代谢和胰岛素抵抗的影响。方法选取2020年3月—2024年3月医院收治的多囊卵巢综合征患者102例为研究对象,51例对照组采用单纯西药治疗,51例观察组在上述基础上予以右归丸、涤痰汤化裁治疗,对比两组临床效果、性激素指标、卵巢及月经情况、糖代谢指标情况。结果观察组与对照组总有效率对比,98.04%高于78.43%,差异有统计学意义(P<0.05)。治疗后,两组血清睾酮(Serum Testosterone,T)、黄体生成素(Luteinizing Hormone,LH)水平较前降低,雌二醇(Estradiol,E_(2))、泌乳素(Prolactin,PRL)、卵泡刺激素(Follicle-Stimulating Hormone,FSH)以及性激素结合球蛋白(Sex Hormone-Binding Globulin,SHBG)较前升高(P<0.05),且与对照组比较,观察组降低/升高更为显著(P<0.05)。治疗后两组卵巢体积、卵泡数目均减少(P<0.05),且与对照组比较,观察组减少更为显著(P<0.05);观察组月经恢复率96.08%,高于对照组的74.51%(P<0.05);观察组卵巢恢复率96.08%,高于对照组的76.47%(P<0.05)。治疗后两组空腹血糖(Fasting Blood Glucose,FBG)、空腹胰岛素(Fasting Insulin,FINS)、2 h血糖(2-hour Plasma Glucose,2 hPG)、性激素结合球蛋白(Sex Hormone-Binding Globulin,SHBG)水平均有所降低(P<0.05),与对照组比较,观察组FBG、FINS、2 hPG以及胰岛素抵抗指数(HOMA-IR)水平降低更为明显(P<0.05)。结论被诊断为多囊卵巢综合征的患者使用药物、右归丸、涤痰汤化裁联合治疗后,治疗效果显著,可有效改善患者的激素水平,改善其糖代谢指标,促进患者恢复。 展开更多
关键词 多囊卵巢综合征 西药治疗 右归丸、涤痰汤化裁 内分泌激素代谢 胰岛素抵抗
原文传递
右归丸活性成分对成骨-破骨共育体系Wnt/β-catenin、OPG/RANKL/RANK通路相关因子mRNA表达的影响
18
作者 章建华 裘佳韦 +2 位作者 商佳璐 叶怡馨 尹华 《中华中医药杂志》 北大核心 2025年第7期3456-3463,共8页
目的:明确右归丸活性成分乌头碱类、松脂醇葡萄糖苷、肉桂酸等对成骨(OB)-破骨(OC)共育体系Wnt/β-catenin、OPG/RANKL/RANK通路相关因子LRP6、LRP5、β-catenin等mRNA表达的调控作用。方法:分别用MC3T3-E1和RAW264.7诱导培养OB和OC并... 目的:明确右归丸活性成分乌头碱类、松脂醇葡萄糖苷、肉桂酸等对成骨(OB)-破骨(OC)共育体系Wnt/β-catenin、OPG/RANKL/RANK通路相关因子LRP6、LRP5、β-catenin等mRNA表达的调控作用。方法:分别用MC3T3-E1和RAW264.7诱导培养OB和OC并进行鉴定,以Transwell共培养建立OB-OC共育体系;分别制备右归丸活性成分乌头碱、次乌头碱、新乌头碱、苯甲酰乌头原碱、苯甲酰次乌头原碱、苯甲酰新乌头原碱、松脂醇二葡萄糖苷、肉桂酸的单体干预液,并采用RT-qPCR法检测细胞中LRP6、LRP5、β-catenin、TCF7、Fzd2、OPG、TRAF6、NFATc1、c-Fos、MMP9、CTSK、Car2 mRNA的表达。结果:成功诱导OB和OC,并建立OB-OC共育体系;右归丸活性成分中乌头碱、次乌头碱、新乌头碱、苯甲酰乌头原碱、苯甲酰新乌头原碱、松脂醇二葡萄糖苷、肉桂酸能上调OB-OC共育体系中Wnt/β-catenin通路LRP6、LRP5、β-catenin、TCF7、Fzd2 mRNA表达水平;次乌头碱、新乌头碱、苯甲酰乌头原碱、苯甲酰新乌头原碱、松脂醇二葡萄糖能上调OPG/RANKL/RANK通路OPG mRNA表达水平;乌头碱、次乌头碱、新乌头碱、苯甲酰乌头原碱、苯甲酰次乌头原碱、苯甲酰新乌头原碱、松脂醇二葡萄糖苷、肉桂酸能抑制OPG/RANKL/RANK通路TRAF6、NFATc1、c-Fos、MMP9、CTSK、Car2 mRNA水平的表达。结论:右归丸活性成分可以通过调控Wnt/β-catenin、OPG/RANKL/RANK通路相关因子的基因表达,促进骨形成,抑制骨吸收,重建骨代谢平衡,起到治疗骨质疏松肾阳虚证的作用。 展开更多
关键词 右归丸活性成分 成骨-破骨共育体系 Wnt/β-catenin通路 OPG/RANKL/RANK通路 mRNA
原文传递
左、右归丸调控PGC-1α介导PMOP大鼠骨髓线粒体生物机制 被引量:4
19
作者 杨莹 冯秀芝 +3 位作者 陈怡然 王智民 郭晛 任艳玲 《中国骨质疏松杂志》 北大核心 2025年第2期163-168,203,共7页
目的以中医“阳化气、阴成形”理论为出发点,探讨“阴阳互济”法介导PGC-1α对PMOP发病过程中线粒体生物发生的影响,为左、右归丸防治PMOP奠定更多理论依据。方法将100只SD大鼠随机分为SHAM、OVX、ZGW、YGW、BJL组,每组20只。除SHAM组外... 目的以中医“阳化气、阴成形”理论为出发点,探讨“阴阳互济”法介导PGC-1α对PMOP发病过程中线粒体生物发生的影响,为左、右归丸防治PMOP奠定更多理论依据。方法将100只SD大鼠随机分为SHAM、OVX、ZGW、YGW、BJL组,每组20只。除SHAM组外,其余组切除双侧卵巢,造模3 d后按组别灌胃12周。采用Micro-CT检测大鼠左侧股骨近端骨分析参数;HE染色法观察骨组织形态;ELISA法检测血清BGP、PICP的含量;比色法检测血清TRACP含量;Western Blot法检测骨髓组织中成脂相关蛋白PPARγ、C/EBPα、CD36、FSP27、Adipoq,骨髓脂肪相关蛋白PGC-1α、UCP1、DIO2、PRDM16以及线粒体生物发生相关NRF1、NRF2、TFAM蛋白表达水平。结果与SHAM组比较,OVX组BMD、BV/TV、Ct.Th、Tb.Th、Conn D表达降低(P<0.01);骨小梁稀疏变细,髓腔内脂肪细胞增多,脂滴体积变大;血清BGP、PICP、TRACP含量显著升高(P<0.01);PPARγ、C/EBPα、CD36、FSP27蛋白表达均显著上调(P<0.01),Adipoq、PGC-1α、UCP1、DIO2、PRDM16、NRF1、NRF2、TFAM蛋白表达显示下调(P<0.01)。与OVX组比较,各给药组的骨分析参数明显改善(P<0.05,P<0.01);骨小梁增粗、数量增多、骨形态结构明显增强;脂肪细胞减少;血清BGP、PICP、TRACP含量显著降低(P<0.01);PPARγ、C/EBPα、CD36、FSP27蛋白表达下调,Adiopq、PGC1-α、UCP1、DIO2、NRF1、NRF2、TFAM蛋白表达上调(P<0.05,P<0.01)。结论左、右归丸均可调控PGC-1α影响骨髓脂肪累积,提高线粒体生物发生水平以防治PMOP。 展开更多
关键词 左归丸 右归丸 绝经后骨质疏松症 PGC-1Α 线粒体生物发生
暂未订购
左、右归丸干预PGC-1α/PPARγ对骨髓间充质干细胞线粒体生物发生的影响 被引量:3
20
作者 杨莹 冯秀芝 +3 位作者 陈怡然 王智民 郭晛 任艳玲 《中国实验方剂学杂志》 北大核心 2025年第9期28-36,共9页
目的:基于“阳化气,阴成形”理论,探讨左、右归丸通过过氧化物酶体增殖激活受体γ共激活因子-1α(PGC-1α)及过氧化物酶体增殖物激活受体γ(PPARγ)影响大鼠骨髓间充质干细胞成脂分化过程中线粒体生物发生的分子机制,为左、右归丸防治... 目的:基于“阳化气,阴成形”理论,探讨左、右归丸通过过氧化物酶体增殖激活受体γ共激活因子-1α(PGC-1α)及过氧化物酶体增殖物激活受体γ(PPARγ)影响大鼠骨髓间充质干细胞成脂分化过程中线粒体生物发生的分子机制,为左、右归丸防治绝经后骨质疏松症(PMOP)奠定更多理论依据。方法:将骨髓间充质干细胞(BMSCs)分为成脂诱导组(模型组)、左归丸组、右归丸组、补佳乐组,采用流式细胞仪进行细胞鉴定;噻唑蓝(MTT)比色法绘制BMSCs的生长曲线,并检测左、右归丸对BMSCs增殖的影响;油红O染色法检测脂滴的形成;蛋白免疫印迹法(Western blot)检测成脂相关因子PPARγ、CCAAT增强子结合蛋白(C/EBP)α、C/EBPβ、脂蛋白脂肪酶(LPL)蛋白,棕色脂肪相关蛋白PGC-1α、解偶联蛋白1(UCP1)、PR结构域蛋白16(PRDM16)蛋白,线粒体生物发生相关PGC-1α、核呼吸因子1(Nrf1)、核转录因子红系2相关因子2(Nrf2)、线粒体转录因子A(TFAM)蛋白的表达;实时荧光定量聚合酶链式反应(Real-time PCR)检测成脂相关因子PPARγ、C/EBPα、C/EBPβ、LPL mRNA及细胞色素B(CytoB)基因拷贝数的表达;透射电镜观察线粒体超微结构。结果:与模型组比较,各给药组BMSCs增殖能力随干预时间增强而增强,药物干预后脂滴明显减少,成脂相关PPARγ、C/EBPα、C/EBPβ、LPL mRNA及蛋白表达水平显著下调(P<0.01);棕色脂肪相关PGC-1α、UCP1、PRDM16蛋白表达水平显著上调(P<0.01);线粒体数量增多,肿胀减少,双层膜和嵴结构清晰,同时内嵴断裂减少;CytoB基因拷贝数显著上调(P<0.01);线粒体生物发生相关PGC-1α、Nrf1、Nrf2、TFAM蛋白表达水平显著上调(P<0.01)。结论:左、右归丸均能通过PGC-1α/PPARγ影响BMSCs线粒体生物发生以防治PMOP。 展开更多
关键词 左归丸 右归丸 绝经后骨质疏松症 过氧化物酶体增殖激活受体γ共激活因子-1α(PGC-1α) 线粒体生物发生
原文传递
上一页 1 2 21 下一页 到第
使用帮助 返回顶部